COVID-19 Case Fatality Rate and Factors Contributing to Mortality in Ethiopia: A Systematic Review of Current Evidence.

COVID-19 Ethiopia case fatality rate coronavirus mortality

Journal

Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216

Informations de publication

Date de publication:
2022
Historique:
received: 03 04 2022
accepted: 29 06 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 12 7 2022
Statut: epublish

Résumé

The ongoing novel coronavirus disease 2019 (COVID-19) is triggering significant morbidity and mortality due to its contagious nature and absence of definitive management. In Ethiopia, despite a number of primary studies have been conducted to estimate the case fatality rate (CFR) of COVID-19, no review study has attempted to summarize the findings to better understand the nature of pandemics and the virulence of the disease. To summarize the CFR of COVID-19 and factors contributing to mortality in Ethiopia. PRISMA guideline was followed. PubMed, Science Direct, CINAHL, SCOPUS, Hinari, and Google Scholar were systematically searched using pre-specified keywords. Observational studies ie, cohort, cross-sectional, and case-control studies were included. The Newcastle-Ottawa scale adapted for observational studies was used to assess the quality of included studies. CFR was defined as the proportion of COVID-19 cases with the outcome of death within a given period. Factors contributing to COVID-19 mortality at p-value <0.05 were described narratively from the eligible articles. A total of 13 observational studies were included in this study. Consequently, this review confirmed the CFR of COVID-19 in Ethiopia ranges between 1-20%. Additionally, comorbid conditions, older age group, male sex, substance use, clinical manifestations (abnormal oxygen saturation level, atypical lymphocyte count, fever, and shortness of breath), disease severity, and history of surgery/trauma increased the likelihood of death from COVID-19 death. This study shows that the range of CFR of COVID-19 in Ethiopia is almost equivalent to other countries, despite the country's low testing capacity and case detection rate in reference to its total population. Comorbid diseases, older age group, male sex, cigarette smoking, alcohol drinking, clinical manifestations and disease severity, and history of surgery/trauma were factors contributing to COVID-19 mortality in Ethiopia. Therefore, given the alarming global situation and rapidly evolving large-scale pandemics, urgent interdisciplinary interventions should be implemented in those vulnerable groups to lessen the risk of mortality. Furthermore, the CFR of COVID-19 should be estimated from all treatment and rehabilitation centers in the country, as underestimation could be linked to a lack of preparedness and mitigation. A large set of prospective studies are also compulsory to better understand the CFR of COVID-19 in Ethiopia.

Sections du résumé

Background UNASSIGNED
The ongoing novel coronavirus disease 2019 (COVID-19) is triggering significant morbidity and mortality due to its contagious nature and absence of definitive management. In Ethiopia, despite a number of primary studies have been conducted to estimate the case fatality rate (CFR) of COVID-19, no review study has attempted to summarize the findings to better understand the nature of pandemics and the virulence of the disease.
Objective UNASSIGNED
To summarize the CFR of COVID-19 and factors contributing to mortality in Ethiopia.
Methods UNASSIGNED
PRISMA guideline was followed. PubMed, Science Direct, CINAHL, SCOPUS, Hinari, and Google Scholar were systematically searched using pre-specified keywords. Observational studies ie, cohort, cross-sectional, and case-control studies were included. The Newcastle-Ottawa scale adapted for observational studies was used to assess the quality of included studies. CFR was defined as the proportion of COVID-19 cases with the outcome of death within a given period. Factors contributing to COVID-19 mortality at p-value <0.05 were described narratively from the eligible articles.
Results UNASSIGNED
A total of 13 observational studies were included in this study. Consequently, this review confirmed the CFR of COVID-19 in Ethiopia ranges between 1-20%. Additionally, comorbid conditions, older age group, male sex, substance use, clinical manifestations (abnormal oxygen saturation level, atypical lymphocyte count, fever, and shortness of breath), disease severity, and history of surgery/trauma increased the likelihood of death from COVID-19 death.
Conclusion UNASSIGNED
This study shows that the range of CFR of COVID-19 in Ethiopia is almost equivalent to other countries, despite the country's low testing capacity and case detection rate in reference to its total population. Comorbid diseases, older age group, male sex, cigarette smoking, alcohol drinking, clinical manifestations and disease severity, and history of surgery/trauma were factors contributing to COVID-19 mortality in Ethiopia. Therefore, given the alarming global situation and rapidly evolving large-scale pandemics, urgent interdisciplinary interventions should be implemented in those vulnerable groups to lessen the risk of mortality. Furthermore, the CFR of COVID-19 should be estimated from all treatment and rehabilitation centers in the country, as underestimation could be linked to a lack of preparedness and mitigation. A large set of prospective studies are also compulsory to better understand the CFR of COVID-19 in Ethiopia.

Identifiants

pubmed: 35813083
doi: 10.2147/IDR.S369266
pii: 369266
pmc: PMC9270043
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

3491-3501

Informations de copyright

© 2022 Girma et al.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest in relation to this work.

Références

PLoS One. 2021 Mar 15;16(3):e0246087
pubmed: 33720944
Lancet Glob Health. 2021 Jan;9(1):e14-e15
pubmed: 33160453
Rev Inst Med Trop Sao Paulo. 2020 Jun 22;62:e43
pubmed: 32578683
Pan Afr Med J. 2021 Apr 12;38:351
pubmed: 34367430
Eur Rev Med Pharmacol Sci. 2020 May;24(9):5180-5182
pubmed: 32432785
BMJ Open. 2021 Mar 29;11(3):e046764
pubmed: 33782023
Pan Afr Med J. 2021 Feb 25;38:217
pubmed: 34046123
Eur Respir J. 2020 Jun 11;55(6):
pubmed: 32341104
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Front Physiol. 2020 Dec 09;11:588553
pubmed: 33362576
Arch Med Res. 2022 Apr;53(3):323-328
pubmed: 35123809
Am J Trop Med Hyg. 2020 Dec 30;104(2):532-536
pubmed: 33382029
Infect Dis Poverty. 2020 Sep 16;9(1):131
pubmed: 32938497
BMC Infect Dis. 2021 Aug 21;21(1):855
pubmed: 34418980
Int J Infect Dis. 2021 Apr;105:776-783
pubmed: 33741488
Br J Cancer. 2021 Aug;125(5):658-671
pubmed: 34135471
J Prev Med Hyg. 2021 Jul 30;62(2):E311-E320
pubmed: 34604571
Public Health. 2022 Apr;205:6-13
pubmed: 35219128
PLoS One. 2021 Mar 15;16(3):e0248281
pubmed: 33720975
Infect Drug Resist. 2021 Dec 14;14:5363-5373
pubmed: 34938084
Ethiop J Health Sci. 2020 Sep;30(5):645-652
pubmed: 33911824
Sci Rep. 2020 Nov 3;10(1):18909
pubmed: 33144595
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
BMJ Open. 2021 Oct 7;11(10):e051506
pubmed: 34620662
Int J Clin Pract. 2021 Oct;75(10):e14614
pubmed: 34535055
Arch Public Health. 2021 Aug 21;79(1):150
pubmed: 34419145
PLoS One. 2021 Nov 9;16(11):e0259454
pubmed: 34752481
Ann Transl Med. 2020 May;8(9):576
pubmed: 32566603
Curr Health Sci J. 2021 Apr-Jun;47(2):270-274
pubmed: 34765248
BMC Musculoskelet Disord. 2022 Jan 18;23(1):64
pubmed: 35042507
Arch Intern Med. 2004 Nov 8;164(20):2206-16
pubmed: 15534156
PLoS One. 2021 Jun 10;16(6):e0252389
pubmed: 34111146
Clin Immunol. 2020 Jun;215:108427
pubmed: 32325252
Nutrients. 2021 May 10;13(5):
pubmed: 34068824
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
J Med Virol. 2020 Sep;92(9):1484-1490
pubmed: 32369222
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Biomed Res Int. 2022 Feb 23;2022:4551132
pubmed: 35252447
JACC Case Rep. 2020 Jul 15;2(9):1407-1410
pubmed: 32373791
J Med Virol. 2022 Jul;94(7):2986-3005
pubmed: 35277864
JAMA Surg. 2020 Aug 1;155(8):691-702
pubmed: 32530453
SAGE Open Med. 2022 Mar 4;10:20503121221081756
pubmed: 35284076
Maturitas. 2021 Dec;154:58-61
pubmed: 34364730
Clin Pathol. 2022 Feb 3;15:2632010X221075584
pubmed: 35141522
PLoS One. 2020 Dec 28;15(12):e0244171
pubmed: 33370364
Pan Afr Med J. 2020 Sep 11;37(Suppl 1):7
pubmed: 33294108

Auteurs

Derara Girma (D)

Public Health Department, College of Health Sciences, Salale University, Fitche, Ethiopia.

Hiwot Dejene (H)

Public Health Department, College of Health Sciences, Salale University, Fitche, Ethiopia.

Leta Adugna (L)

Public Health Department, College of Health Sciences, Salale University, Fitche, Ethiopia.

Mengistu Tesema (M)

Public Health Department, College of Health Sciences, Salale University, Fitche, Ethiopia.

Mukemil Awol (M)

Department of Midwifery, College of Health Sciences, Salale University, Fiche, Ethiopia.

Classifications MeSH